Biotech Values

[BTH]

Heck, even CRIS/RHHBY got pushed through with a small 100 pt open-label Phase 2 in mBCC, aBCC.
Certainly not unheard of, if they target a specific unmet pt population.

They need a real partner for this though; if they do it alone, I can really see them screwing this up badly - heck, they couldnt even check the right box at ASCO.